Company / Total Assets
Centessa Pharmaceuticals plc Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$687.5M
FY2025
5-year range
$360.2M / $687.5M
FY2021-FY2025
Trend
+19.2%
vs FY2024
Sector context
#112 of 214
Health Care
What the data says
At $687M, Centessa Pharmaceuticals plc's total assets ranks #112 of 214 in the Health Care sector. Improved from $360M to $687M over the past 2 years.
Based on SEC 10-K filings.
$687M in FY2025 with a 5-year CAGR of +125.8%.
Improved from $360M to $687M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +15.7%
- 5-Year CAGR
- +125.8%
- 10-Year CAGR
- -
Sector benchmark
#112 of 214 in Health CareTop 52% of 214This company $687.5M Sector average $7.5B
▼
-90.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +125.8%, indicating consistent growth.
- In FY2025, total assets increased 19.2% year-over-year.
- Ranks #112 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $687.5M | +19.2% |
| FY2024 | $576.8M | +60.1% |
| FY2023 | $360.2M | -18.9% |
| FY2022 | $444.3M | -29.4% |
| FY2021 | $629.6M | +5273.7% |
| FY2020 | $11.7M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026